Cardiology MedTech Structural Heart

Which TAVR device is the best? It depends, researchers say

Released on September 10, 2020

  Researchers published a paper in the Journal of the American Medical Association citing insufficient evidence regarding the superiority of TAVR devices. […]

Read more
Cardiology FDA Structural Heart

Medtronic tricuspid valve replacement device wins FDA breakthrough status

Released on September 9, 2020

Dive Brief: Medtronic on Wednesday simultaneously announced FDA breakthrough device designation and kickoff of an early feasibility study for a transcatheter tricuspid […]

Read more
Cardiology MedTech Structural Heart

BioVentrix Resumes Pivotal Trial That Was Interrupted by COVID-19

Released on September 7, 2020

San Ramon, CA-based BioVentrix is developing a hybrid transcatheter device for left ventricular remodeling after a heart attack. The pivotal trial […]

Read more
Cardiology FDA Approved Structural Heart

FDA approves expanded use for Medtronic’s Evolut TAVR

Released on August 25, 2020

Medtronic (NYSE:MDT) announced last week that it received FDA approval for revised commercial labeling on its Evolut TAVR platform. Fridley, Minn.-based Medtronic […]

Read more
Cardiology Funding Structural Heart

Neovasc raises $12.6M

Released on August 11, 2020

Neovasc (NSDQ:NVCN) announced today that it agreed to sell shares of its common stock in a registered direct offering worth approximately $12.6 […]

Read more
Cardiology Funding Structural Heart

Conformal Medical raises $70 million

Released on August 10, 2020

Stroke prevention technology developer Conformal Medical filed an SEC Form D to confirm the sale of $70 million in an equity offering. Nashua, […]

Read more
Cardiology Structural Heart Vascular

Confluent Medical opens catheter development center in Austin, Texas

Released on August 10, 2020

Confluent Medical this week announced it has opened a Complex Catheter Design and Development Center in Austin, Texas. The facility is […]

Read more
Cardiology FDA Structural Heart

FDA issues EUA for Abiomed Impella heart pumps for COVID-19 therapy

Released on August 4, 2020

Abiomed (NSDQ:ABMD) announced today that the FDA issued emergency use authorization (EUA) for its Impella heart pumps in COVID-19 therapy. The EUA […]

Read more
Cardiology MedTech Structural Heart

Edwards aims for 5% TAVR sales growth in 2020 after seeing demand bounce back

Released on July 24, 2020

Dive Brief: Edwards Lifesciences raised expectations for 2020 transcatheter aortic valve replacement (TAVR) sales in a report to investors Thursday after seeing […]

Read more
Cardiology MedTech Structural Heart

Edwards Lifesciences Q2 results are better than expected

Released on July 23, 2020

Edwards Lifesciences (NYSE:EW) stock has jumped in after-hours trading after the company reported Street-beating Q2 results and boosted it earnings outlook. The […]

Read more
Cardiology FDA Structural Heart

Boston Sci Wins Nod for Next Gen Watchman Device

Released on July 22, 2020

Boston Scientific has won a nod from FDA for the latest generation of the Watchman Left Atrial Appendage Closure (LAAC) technology. […]

Read more
Cardiology FDA Approved Structural Heart

Boston Scientific’s next-gen stroke prevention device gets FDA nod

Released on July 21, 2020

The FDA has approved the next-generation of Boston Scientific’s (NYSE:BSX) Watchman left atrial appendage closure (LAAC) device, the company announced today. The Marlborough, […]

Read more